Autoimmune Diseases

Autoimmune diseases occur when the body produces antibodies that attack its own tissues and organs. Years ago, during my research, I discovered a fascinating article suggesting that autoimmune antibodies are influenced by Th1 lymphocytes which can be inhibited by omega-3 fatty acids.

Shortly after, I was contacted by a woman suffering from Graves’ disease—a thyroiditis causing severe nervousness, stress and eye complications. Conventional treatments had failed, leaving her desperate.

Based on my research, I recommended fish oil in the morning and evening alongside eliminating red meat to modulate her immune response. To address the risk of viral infections caused by blocking Th1 lymphocytes, I added antioxidants to inhibit the NFKappa B enzyme which supports viral replication.

Within four weeks, her nervousness subsided and her antibodies disappeared. Seven weeks later, the deposits behind her eyes causing vision issues resolved.

A similar approach successfully addressed Hashimoto’s disease in another patient. This autoimmune thyroid condition, which had left her fatigued and unwell, saw her return to health in just four weeks with antibodies disappearing entirely.

Even complex cases like rheumatoid arthritis responded positively. One patient, with debilitating pain and an antibody count of 800, achieved complete remission within four weeks with her antibodies dropping to zero.

Viral Diseases

Viruses generate oxygen radicals that enhance their toxicity often through enzymes like xanthine oxidase (XO) and nitric oxide synthase. This oxidative stress triggers inflammatory cascades culminating in toxic compounds like peroxynitrite. Addressing these pathways is critical in combating viral infections.

For instance, a 4-year-old with splenomegaly (an enlarged spleen at risk of rupture) due to Epstein-Barr virus (EBV) was successfully treated with natural enzyme inhibitors, achieving recovery within 24 hours.

Similar results were seen with other pediatric cases involving EBV and herpes simplex virus with recovery times ranging from 24 to 48 hours. These outcomes showcase the power of targeted, science-backed natural therapies.

Cancer

Cancer’s complexity has driven decades of research but breakthroughs continue to emerge. Collmed was founded after I treated a 39-year-old patient with stage IV breast cancer. Sent home with a prognosis of 12 weeks to live, she turned to me as a last hope.

Using a natural compound derived from frankincense—known for its anti-inflammatory properties—we saw remarkable results. Within 10 weeks, her cancer was gone, defying all expectations.

The emergence of “turbo cancers” presents new challenges but progress is being made. A multifaceted approach targeting cancer’s metabolic environment—through diet, detoxification and natural therapies—has proven effective. For example:

• Dietary Changes: A plant-based diet reduces tumor-stimulating amino acids (methionine, arginine) and decreases cancer growth factors.
• Detoxification: Removing heavy metals, fluoride and pathogens helps stabilize DNA and prevents metabolic disruptions.
• Targeting Tumor Metabolism: Natural compounds and therapies, such as dichloroacetate (DCA), can inhibit cancer cell glycolysis, reducing lactic acid buildup and altering the tumor environment.

Additionally, innovative approaches involving sound therapy, scalar waves and even meditation and prayer have shown promise in reversing cancer progression. While there is still much to learn, these discoveries are opening doors to remission and preventing cancer at its core.

Citations

1. Calder, P. C. (2017). Omega-3 fatty acids and inflammatory processes. Biochemical Society Transactions, 45(5), 1105–1115.
2. Manna, S. K., et al. (2000). Antioxidants suppress activation of nuclear transcription factor NF-kappa B. Journal of Immunology, 164(11), 6509–6519.
3. Becker, K., et al. (2002). Oxidative stress in viral infections. Antioxidants & Redox Signaling, 4(3), 227–237.
4. Ni, X., et al. (2012). Anti-inflammatory and anti-cancer properties of frankincense. Clinical Cancer Research, 18(7), 2135–2147.
5. Matthews, G. M., et al. (2021). Targeting amino acid metabolism for cancer therapy. Nature Reviews Clinical Oncology, 18(12), 707–720.
6. Goyer, R. A. (1997). Toxic and essential metal interactions. Annual Review of Nutrition, 17(1), 37–50.
7. Michelakis, E. D., et al. (2010). Metabolic modulation of cancer through dichloroacetate. Science Translational Medicine, 2(31), 31ra34.